Skip to content

Boston Scientific

NYSE: BSX · USD

Boston Scientific cash flow and EPS79

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$390M
Boston Scientific capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q2100% · $74M0% · $0MUnavailableUnavailableUnavailable100% · $74M
FY 2009 Q328.8% · $91M0% · $0MUnavailableUnavailable71.2% · $225M100% · $316M
FY 2009 Q43.98% · $87M0% · $0MUnavailableUnavailable96.02% · $2,100M100% · $2,187M
FY 2010 Q1100% · $70MUnavailableUnavailableUnavailable0% · $0M100% · $70M
FY 2010 Q26.35% · $61MUnavailableUnavailableUnavailable93.65% · $900M100% · $961M
FY 2010 Q3100% · $78MUnavailableUnavailableUnavailable0% · $0M100% · $78M
FY 2010 Q49.5% · $63MUnavailableUnavailableUnavailable90.5% · $600M100% · $663M
FY 2011 Q17.35% · $69M39.4% · $370MUnavailableUnavailable53.25% · $500M100% · $939M
FY 2011 Q29.96% · $83M0% · $0MUnavailableUnavailable90.04% · $750M100% · $833M
FY 2011 Q326.44% · $69M0% · $0M73.56% · $192MUnavailable0% · $0M100% · $261M
FY 2011 Q421.67% · $83M0% · $0M78.33% · $300MUnavailable0% · $0M100% · $383M
FY 2012 Q132.35% · $66MUnavailable67.65% · $138MUnavailableUnavailable100% · $204M
FY 2012 Q231.71% · $52MUnavailable68.29% · $112MUnavailableUnavailable100% · $164M
FY 2012 Q315.54% · $46M0% · $0M84.46% · $250MUnavailable0% · $0M100% · $296M
FY 2012 Q415.7% · $62M58.73% · $232M25.32% · $100MUnavailable0.25% · $1M100% · $395M
FY 2013 Q134.64% · $53M0% · $0M65.36% · $100MUnavailableUnavailable100% · $153M
FY 2013 Q233.77% · $51M0% · $0M66.23% · $100MUnavailableUnavailable100% · $151M
FY 2013 Q33.6% · $57M0% · $0M4.74% · $75MUnavailable91.66% · $1,450M100% · $1,582M
FY 2013 Q414.41% · $84M47% · $274M38.59% · $225MUnavailable0% · $0M100% · $583M
FY 2014 Q130.73% · $59M4.17% · $8M65.1% · $125MUnavailableUnavailable100% · $192M
FY 2014 Q250.39% · $65M49.61% · $64M0% · $0MUnavailableUnavailable100% · $129M
FY 2014 Q311.89% · $56M88.11% · $415M0% · $0MUnavailable0% · $0M100% · $471M
FY 2014 Q4100% · $79MUnavailable0% · $0MUnavailable0% · $0M100% · $79M
FY 2015 Q1100% · $46M0% · $0M0% · $0MUnavailableUnavailable100% · $46M
FY 2015 Q242.2% · $46M57.8% · $63M0% · $0MUnavailableUnavailable100% · $109M
FY 2015 Q34.24% · $70M95.76% · $1,579M0% · $0MUnavailable0% · $0M100% · $1,649M
FY 2015 Q425.99% · $85M28.13% · $92M0% · $0MUnavailable45.87% · $150M100% · $327M
FY 2016 Q1100% · $60MUnavailableUnavailableUnavailable0% · $0M100% · $60M
FY 2016 Q223.78% · $78MUnavailableUnavailableUnavailable76.22% · $250M100% · $328M
FY 2016 Q350.35% · $71M49.65% · $70MUnavailableUnavailable0% · $0M100% · $141M
FY 2016 Q433.07% · $167M66.93% · $338MUnavailableUnavailable0% · $0M100% · $505M
FY 2017 Q130.94% · $112M0% · $0MUnavailableUnavailable69.06% · $250M100% · $362M
FY 2017 Q28.4% · $68M48.4% · $392MUnavailableUnavailable43.21% · $350M100% · $810M
FY 2017 Q313.04% · $60M0% · $0MUnavailableUnavailable86.96% · $400M100% · $460M
FY 2017 Q431.98% · $79M68.02% · $168MUnavailableUnavailable0% · $0M100% · $247M
FY 2018 Q18.94% · $60M1.34% · $9MUnavailableUnavailable89.72% · $602M100% · $671M
FY 2018 Q215.32% · $74M84.68% · $409MUnavailableUnavailable0% · $0M100% · $483M
FY 2018 Q312.14% · $76M87.86% · $550MUnavailableUnavailable0% · $0M100% · $626M
FY 2018 Q418.09% · $106M81.91% · $480MUnavailableUnavailable0% · $0M100% · $586M
FY 2019 Q13.39% · $63M17.3% · $321MUnavailableUnavailable79.31% · $1,472M100% · $1,856M
FY 2019 Q217.07% · $91M82.93% · $442MUnavailableUnavailable0% · $0M100% · $533M
FY 2019 Q33.24% · $121M96.76% · $3,619MUnavailableUnavailable0% · $0M100% · $3,740M
FY 2019 Q48.18% · $186M0% · $0MUnavailable0% · $0M91.82% · $2,088M100% · $2,274M
FY 2020 Q1100% · $100M0% · $0MUnavailable0% · $0MUnavailable100% · $100M
FY 2020 Q295.77% · $68M4.23% · $3MUnavailable0% · $0MUnavailable100% · $71M
FY 2020 Q377.78% · $49M0% · $0MUnavailable22.22% · $14MUnavailable100% · $63M
FY 2020 Q491.91% · $159M0% · $0MUnavailable8.09% · $14MUnavailable100% · $173M
FY 2021 Q19.43% · $75M88.81% · $706MUnavailable1.76% · $14MUnavailable100% · $795M
FY 2021 Q288.33% · $106M0% · $0MUnavailable11.67% · $14MUnavailable100% · $120M
FY 2021 Q37.49% · $107M91.53% · $1,308MUnavailable0.98% · $14MUnavailable100% · $1,429M
FY 2021 Q450.86% · $266M46.65% · $244MUnavailable2.49% · $13MUnavailable100% · $523M
FY 2022 Q17.53% · $121M91.59% · $1,471MUnavailable0.87% · $14MUnavailable100% · $1,606M
FY 2022 Q288.24% · $105M0% · $0MUnavailable11.76% · $14MUnavailable100% · $119M
FY 2022 Q363.83% · $150M30.21% · $71MUnavailable5.96% · $14MUnavailable100% · $235M
FY 2022 Q494.22% · $212M0% · $0MUnavailable5.78% · $13MUnavailable100% · $225M
FY 2023 Q122.2% · $111M75% · $375MUnavailable2.8% · $14MUnavailable100% · $500M
FY 2023 Q217.88% · $143M80.38% · $643MUnavailable1.75% · $14MUnavailable100% · $800M
FY 2023 Q3100% · $190M0% · $0MUnavailable0% · $0MUnavailable100% · $190M
FY 2023 Q425.19% · $267M74.81% · $793MUnavailable0% · $0MUnavailable100% · $1,060M
FY 2024 Q179.2% · $179M20.8% · $47MUnavailable0% · $0MUnavailable100% · $226M
FY 2024 Q276.35% · $155M23.65% · $48MUnavailable0% · $0MUnavailable100% · $203M
FY 2024 Q313.71% · $179M86.29% · $1,127MUnavailable0% · $0MUnavailable100% · $1,306M
FY 2024 Q47.5% · $277M92.5% · $3,418MUnavailable0% · $0MUnavailable100% · $3,695M
FY 2025 Q143.9% · $187M56.1% · $239MUnavailableUnavailableUnavailable100% · $426M
FY 2025 Q213.46% · $157M86.54% · $1,009MUnavailableUnavailableUnavailable100% · $1,166M
FY 2025 Q341.42% · $181M58.58% · $256MUnavailableUnavailableUnavailable100% · $437M
FY 2025 Q479.77% · $351M20.23% · $89MUnavailableUnavailableUnavailable100% · $440M
FY 2026 Q125.29% · $177M74.71% · $523MUnavailableUnavailableUnavailable100% · $700M
FY 2026 Q250% · $195M50% · $195MUnavailableUnavailableUnavailable100% · $390M
Jun 30, 2009 through Jun 30, 2026

Latest period omits buybacks, dividends, debt repayments. Percentages cover tracked uses. SBC is noncash and excluded.

Operating cash flow

USD millions

$1,474M

Capital expenditures

USD millions

$195M

Free cash flow

USD millions

$1,279M

Stock-based compensation

USD millions

$87M

SBC / free cash flow

% · FCF before SBC deduction

6.8%

SBC / operating cash flow

%

5.9%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$0.61

Quarterly data

Boston Scientific cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 20261,4741951,279876.8%5.9%—$0.61
FY 2026 Q1Mar 31, 20263481771718348.54%23.85%—$0.9
FY 2025 Q4Dec 31, 20251,3643511,013717.01%5.21%——
FY 2025 Q3Sep 30, 20251,3431811,162796.8%5.88%—$0.51
FY 2025 Q2Jun 30, 20251,2861571,129756.64%5.83%—$0.53
FY 2025 Q1Mar 31, 20255411873547420.9%13.68%—$0.45
FY 2024 Q4Dec 31, 20241,4562771,179695.85%4.74%——
FY 2024 Q3Sep 30, 20241,002179823688.26%6.79%—$0.32
FY 2024 Q2Jun 30, 20248131556586610.03%8.12%—$0.22
FY 2024 Q1Mar 31, 2024164179-1563—38.41%—$0.33
FY 2023 Q4Dec 31, 2023957267690598.55%6.17%——
FY 2023 Q3Sep 30, 20236981905085911.61%8.45%—$0.34
FY 2023 Q2Jun 30, 20236581435156011.65%9.12%—$0.18
FY 2023 Q1Mar 31, 2023190111795569.62%28.95%—$0.21
FY 2022 Q4Dec 31, 2022807212595559.24%6.82%——
FY 2022 Q3Sep 30, 20224701503205818.13%12.34%—$0.12
FY 2022 Q2Jun 30, 20223071052025527.23%17.92%—$0.17
FY 2022 Q1Mar 31, 2022-58121-17952———$0.07
FY 2021 Q4Dec 31, 20214782662124923.11%10.25%——
FY 2021 Q3Sep 30, 20214651073585114.25%10.97%—$0.28
FY 2021 Q2Jun 30, 2021643106537478.75%7.31%—$0.12
FY 2021 Q1Mar 31, 2021284752094722.49%16.55%—$0.23
FY 2020 Q4Dec 31, 2020673159514428.17%6.24%——
FY 2020 Q3Sep 30, 202064349594406.73%6.22%—$-0.12
FY 2020 Q2Jun 30, 2020269682014622.89%17.1%—$-0.11
FY 2020 Q1Mar 31, 2020-77100-17742———$0.01
FY 2019 Q4Dec 31, 2019692186506418.1%5.92%——
FY 2019 Q3Sep 30, 20195021213814211.02%8.37%—$0.09
FY 2019 Q2Jun 30, 2019292912013818.91%13.01%—$0.11
FY 2019 Q1Mar 31, 2019350632873612.54%10.29%—$0.3
FY 2018 Q4Dec 31, 201819106-8736—189.47%——
FY 2018 Q3Sep 30, 201850176425368.47%7.19%—$0.31
FY 2018 Q2Jun 30, 2018-40374-47732———$0.4
FY 2018 Q1Mar 31, 2018193601333627.07%18.65%—$0.21
FY 2017 Q4Dec 31, 201787279793313.91%3.56%——
FY 2017 Q3Sep 30, 2017255601953417.44%13.33%—$0.2
FY 2017 Q2Jun 30, 2017185681173227.35%17.3%—$0.11
FY 2017 Q1Mar 31, 20171141122301,500%26.32%—$0.21
FY 2016 Q4Dec 31, 2016466167299299.7%6.22%——
FY 2016 Q3Sep 30, 2016-3171-10229———$0.17
FY 2016 Q2Jun 30, 201642178343308.75%7.13%—$-0.15
FY 2016 Q1Mar 31, 201611660562850%24.14%—$0.15
FY 2015 Q4Dec 31, 2015329852442811.48%8.51%——
FY 2015 Q3Sep 30, 201540870338267.69%6.37%—$-0.15
FY 2015 Q2Jun 30, 201560461427192.86%45%—$0.08
FY 2015 Q1Mar 31, 2015-19746-24326———$0
FY 2014 Q4Dec 31, 201444079361246.65%5.45%——
FY 2014 Q3Sep 30, 201434656290268.97%7.51%—$0.03
FY 2014 Q2Jun 30, 2014285652202712.27%9.47%—$0
FY 2014 Q1Mar 31, 2014198591392618.71%13.13%—$0.1
FY 2013 Q4Dec 31, 2013273841892814.81%10.26%——
FY 2013 Q3Sep 30, 2013250571932713.99%10.8%—$0
FY 2013 Q2Jun 30, 201339651345267.54%6.57%—$0.1
FY 2013 Q1Mar 31, 2013163531102421.82%14.72%—$-0.26
FY 2012 Q4Dec 31, 201236962307237.49%6.23%——
FY 2012 Q3Sep 30, 2012272462262812.39%10.29%—$-0.48
FY 2012 Q2Jun 30, 201240752355308.45%7.37%—$-2.51
FY 2012 Q1Mar 31, 2012212661462718.49%12.74%—$0.08
FY 2011 Q4Dec 31, 2011349832663212.03%9.17%——
FY 2011 Q3Sep 30, 2011366692973110.44%8.47%—$0.09
FY 2011 Q2Jun 30, 2011390833073310.75%8.46%—$0.1
FY 2011 Q1Mar 31, 2011-9769-16632———$0.03
FY 2010 Q4Dec 31, 201044963386287.25%6.24%—$0.15
FY 2010 Q3Sep 30, 2010-12678-20430———$0.12
FY 2010 Q2Jun 30, 2010286612253616%12.59%—$0.06
FY 2010 Q1Mar 31, 2010-28470-35456———$-1.05
FY 2009 Q4Dec 31, 2009-32987-41633———$-0.71
FY 2009 Q3Sep 30, 200948491393338.4%6.82%—$-0.06
FY 2009 Q2Jun 30, 200941974345339.57%7.88%—$0.1
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · BSX, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.